MICHELLE SAPP: Open Payments
NPI 1619931136 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,357 in 39 payments from 20 companies in 2025. Trend: 2023 $935 · 2024 $2,058 · 2025 $2,357
Food & beverage: $2,312Education: $45
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 4 | $300 |
| SANOFI-AVENTIS U.S. LLC | 4 | $225 |
| Melinta Therapeutics, LLC | 5 | $205 |
| Incyte Corporation | 4 | $178 |
| Janssen Biotech, Inc. | 3 | $143 |
| Deciphera Pharmaceuticals Inc. | 1 | $143 |
| Alexion Pharmaceuticals, Inc. | 2 | $138 |
| BeOne Medicines USA, Inc. | 1 | $131 |
| Janssen Scientific Affairs, LLC | 1 | $130 |
| BeiGene USA, Inc. | 1 | $125 |
Products named: clonoSEQ, BRUKINSA, REZUROCK, CARVYKTI, Rezzayo, NIKTIMVO, QINLOCK, Epkinly.
Industry payments across FL — which companies pay providers there.
